BCR and B-cell chronic lymphocytic leukemia: Here, we review the current understanding of BCR associated biomarker exemplifying a novel IGL mutation, termed IGLV3-21R110 (where a glycine is replaced by arginine at position 110), in severe pathogenesis including stereotypic CLL subset #2 (26–28).